Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular functionFrom Clinical Application to Cognitive Enhancement: The Example of MethylphenidateMethylphenidate in the treatment of children with attention-deficit hyperactivity disorderIndividualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics.Comparing Auditory Noise Treatment with Stimulant Medication on Cognitive Task Performance in Children with Attention Deficit Hyperactivity Disorder: Results from a Pilot Study.The challenges of implementing ADHD clinical guidelines and research best evidence in routine clinical care settings: Delphi survey and mixed-methods study.Packages of care for attention-deficit hyperactivity disorder in low- and middle-income countriesDopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA).Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.Open-label dose optimization of methylphenidate modified release long acting (MPH-LA): a post hoc analysis of real-life titration from a 40-week randomized trial.Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences.Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progressLong-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies.Symptoms of attention-deficit/hyperactivity disorder in long-term survivors of childhood leukemiaPromoting productive interactions between parents and physicians in the treatment of children with attention-deficit/hyperactivity disorder.Growth on stimulant medication; clarifying the confusion: a review.Dissociation between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats in baseline performance and methylphenidate response on measures of attention, impulsivity and hyperactivity in a Visual Stimulus Position Discrimination Task.Child mental health in Latin America: present and future epidemiologic research.Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway.Remediating organizational functioning in children with ADHD: immediate and long-term effects from a randomized controlled trialPharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategiesSensitivity of tests to assess improvement in ADHD symptomatologyTraining sensory signal-to-noise resolution in children with ADHD in a global mental health settingTreatment Sequencing for Childhood ADHD: A Multiple-Randomization Study of Adaptive Medication and Behavioral InterventionsEvidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details.A 7-year-old boy experiencing difficulty at schoolImproving psychostimulant adherence in children with ADHD.Long-term treatment of ADHD with stimulants: a large observational study of real-life patients.Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity.ADHD in school-aged youth: Management and special treatment considerations in the primary care setting.Impact of a Web-Portal Intervention on Community ADHD Care and OutcomesMethylphenidate, interstimulus interval, and reaction time performance of children with attention deficit/hyperactivity disorder: a pilot study.Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression.No beneficial effects of adding parent training to methylphenidate treatment for ADHD + ODD/CD children: a 1-year prospective follow-up study.An Evaluation Approach for the Performance of Dosing Regimens in Attention-Deficit/Hyperactivity Disorder Treatment.Monitoring Attention in ADHD with an Easy-to-Use Electrophysiological Index.Developmental pathways to severe antisocial behavior: interventions for youth with callous-unemotional traits.
P2860
Q22061981-D29F47B0-AC31-4251-9DE8-6B0B93EE72AEQ22252308-04473506-8346-4850-9509-CAD8AAF676C5Q28073785-D8E8B3EA-E159-4592-8441-3E01E595C4F0Q28344200-C4D30A2F-93D6-4BF0-8C48-AA4008A759D5Q30373969-AE69A612-BC24-4D9F-BB89-136E38E63D37Q30374187-A8385C1D-0758-408F-9CA8-9EC6596E4086Q30490041-5ABA3C57-E214-4C07-B0E3-335D90220396Q33534639-84BDBF8B-28D4-40E7-9626-9D31A087EDC6Q33782844-0FD1807B-CBF2-46C1-A949-2E4DE3850511Q33925017-B2CA8CF9-55BF-4383-84C8-D22F52E50760Q34045097-BE3A8EDA-C8FB-4853-9E0A-69A1D955893CQ34085116-DD051A2C-7330-43B4-AFF2-8A09DE835A74Q34554876-C3204FAA-F57D-4BF2-9C2E-7F3BFE6C8376Q34661181-44FD2049-BBA9-40C0-BF33-80EAD9EB902CQ35001357-8DC7708D-7A5D-4616-B28B-FA905E09C013Q35119007-2B8003DC-C3A1-4F16-A31D-F2862145B1C7Q35135055-2FD27D6A-9795-475A-AD10-C8BA49BDB1B4Q35284563-C1818D24-3C08-48EE-ABCF-63156FEE2050Q35329653-19276479-0D54-4419-A5EA-AF13693B097CQ35747754-D9B89039-15B1-4EB8-B96D-6CAF40722C71Q36298408-B57C65B1-282B-44CD-8CCF-026E3F37BA2AQ36545266-C28459DF-B2C5-43DA-8F50-419F322FEBC6Q36740445-7F3404A3-65E1-4175-AB50-A241399439B4Q36882424-1759FB5F-B08F-4B07-A7F6-AD3C4E8BD62BQ36915373-6A0B2475-B671-4573-BB33-05FCACB9FF42Q37059141-D2B1E007-0E68-4055-821F-5C851D736BEBQ37198296-A2373E34-75D1-429A-BD9D-09ECF485F666Q37229676-D887D6CD-F8EB-4BAF-A338-EBA5AFB47969Q37301222-6DCA816F-C342-4074-B8BD-70E9E35710A0Q37772707-58E6CC3B-3ADC-402C-8BF2-6E66FC64A8B2Q38164657-CF8D4AF9-F6D6-4B0E-9683-F23F32A45C8AQ38663434-859A7C85-5326-48F2-BC31-743B2AF0A7A4Q38808573-C79F78FD-6BC8-4D8B-86FF-A8C1A7108870Q42234646-9FF8F289-B794-4089-A65E-847BCD0DFD51Q46083849-D9B5C3E3-F6AB-4489-B225-BCECE4BE1B4DQ46243819-8A871E05-A60A-40A5-90F6-8D5CA858C67CQ46584976-B5B051F2-6D39-4BB9-82D7-E8EB413C1F92Q47766472-FFD9330F-AA5D-47C6-A729-C3E8CA374063Q49469231-0E211E42-0C66-4E43-B37F-735DA66DC2CAQ52118096-56444099-8A99-4A28-BA0D-81F83B024A4A
P2860
Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Methylphenidate dosage for chi ...... ditions: lessons from the MTA.
@ast
Methylphenidate dosage for chi ...... ditions: lessons from the MTA.
@en
type
label
Methylphenidate dosage for chi ...... ditions: lessons from the MTA.
@ast
Methylphenidate dosage for chi ...... ditions: lessons from the MTA.
@en
prefLabel
Methylphenidate dosage for chi ...... ditions: lessons from the MTA.
@ast
Methylphenidate dosage for chi ...... ditions: lessons from the MTA.
@en
P2093
P1476
Methylphenidate dosage for chi ...... nditions: lessons from the MTA
@en
P2093
B Vitiello
D P Cantwell
G R Elliott
H B Abikoff
J B Severe
J M Swanson
L E Arnold
L Hechtman
L L Greenhill
P304
P356
10.1097/00004583-200102000-00013
P577
2001-02-01T00:00:00Z